METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES Russian patent published in 2013 - IPC A61K31/196 A61P1/00 A61K9/22 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely gastroenterology, and may be used for treating a patient suffering an inflammatory intestinal disease. That is ensured by administering 5-aminosalicylic acid (5-ASA) in the form of a controlled-release dosage form. The administration involves: a daily dose making approximately 4.8 g of 5-ASA in the form of the controlled-release dosage form taken in portions of 2.4 g of 5-ASA, twice a day for 8 weeks or a shorter period of time enough to achieve a favourable therapeutic effect. The patient represents a patient who has achieved no post-therapeutic remission for approximately 4-8 weeks with using the initial dosage, which involves. A dose of approximately 2.4 g of 5-ASA in the form of a dose of approximately 1.2 g introduced twice a day, in the form of a dose of approximately 2.4 g once a day, or in the form of approximately 0.8 g three times a day. Or a dose of approximately 4.8 g of 5-ASA once a day in the form of a dose of approximately 4.8 g.

EFFECT: invention provides the remission of the disease in a patient after the failed initial course of 5-ASA due to prolonging the therapy and using the dose of 5-ASA in the controlled release form.

2 dwg, 2 tbl, 2 ex